Cognyte Software press release ( CGNT ): Q4 Non-GAAP EPS of $0.10 beats by $0.06 . Revenue of $106.24M (+12.4% Y/Y) in-line. FYE27 Outlook Our outlook for the year ending January 31, 2027 (“FYE27” and “Fiscal 2027”) is as follows: Revenue: $448 million vs. $442.60M consensus , with a range of +/- 3%, which represents approximately 12% year-over-year growth at the midpoint of the range. Adjusted EB...
Cognyte Software press release ( CGNT ): Q4 Non-GAAP EPS of $0.10 beats by $0.06 . Revenue of $106.24M (+12.4% Y/Y) in-line. FYE27 Outlook Our outlook for the year ending January 31, 2027 (“FYE27” and “Fiscal 2027”) is as follows: Revenue: $448 million vs. $442.60M consensus , with a range of +/- 3%, which represents approximately 12% year-over-year growth at the midpoint of the range. Adjusted EBITDA: Approximately $68 million at the midpoint of our revenue range, representing approximately 40% year-over-year growth. Non-GAAP Diluted EPS: $0.47 at the midpoint of our revenue range vs. $0.37 consensus . More on Cognyte Software Cognyte Software Needs Better Results To Prove The AI Disruption Narrative False Cognyte Software set to report Q4 2026 earnings preview. Cognyte authorizes $20 million increase to share repurchase program Seeking Alpha’s Quant Rating on Cognyte Software Historical earnings data for Cognyte Software
The Middleby ( MIDD ) has appointed Brittany Cerwin as chief financial officer, effective immediately. Cerwin succeeds Bryan Mittelman, who has served as CFO since 2019 and will transition to the role of special advisor to the chief executive officer. Cerwin previously served as chief accounting officer. Source: Press Release More on Middleby The Middleby Corporation (MIDD) Q4 2025 Earnings Call T...
The Middleby ( MIDD ) has appointed Brittany Cerwin as chief financial officer, effective immediately. Cerwin succeeds Bryan Mittelman, who has served as CFO since 2019 and will transition to the role of special advisor to the chief executive officer. Cerwin previously served as chief accounting officer. Source: Press Release More on Middleby The Middleby Corporation (MIDD) Q4 2025 Earnings Call Transcript The Middleby Corporation 2025 Q4 - Results - Earnings Call Presentation Middleby Making Smarter Moves, But Weak Industry Demand Is A Significant Overhang Middleby outlines $3.27B–$3.36B 2026 revenue target as portfolio optimization accelerates Middleby Q4 2025 Earnings Preview
Israel's Defense Minister says the military will take control of southern Lebanon up to the Litani River to prevent Hezbollah from transporting weapons and fighters. Lebanon has withdrawn accreditation from the Iranian ambassador, demanding his departure from the country by Sunday. Bloomberg's Dan Williams spoke to Joumanna Bercetche on Horizons Middle East and Africa. (Source: Bloomberg)
Israel's Defense Minister says the military will take control of southern Lebanon up to the Litani River to prevent Hezbollah from transporting weapons and fighters. Lebanon has withdrawn accreditation from the Iranian ambassador, demanding his departure from the country by Sunday. Bloomberg's Dan Williams spoke to Joumanna Bercetche on Horizons Middle East and Africa. (Source: Bloomberg)
KalVista Pharmaceuticals press release ( KALV ): Q4 GAAP EPS of -$2.03 may not be comparable to estimates. Revenue of $49.08M beats by $16.79M . As of December 31, 2025, the Company had cash, cash equivalents and marketable securities of approximately $300.2 million. We anticipate that cash, cash equivalents and marketable securities as of December 31, 2025, along with projected revenues associate...
KalVista Pharmaceuticals press release ( KALV ): Q4 GAAP EPS of -$2.03 may not be comparable to estimates. Revenue of $49.08M beats by $16.79M . As of December 31, 2025, the Company had cash, cash equivalents and marketable securities of approximately $300.2 million. We anticipate that cash, cash equivalents and marketable securities as of December 31, 2025, along with projected revenues associated with the sale of EKTERLY will fund the Company through profitability. More on KalVista Pharmaceuticals KalVista Pharmaceuticals: Has Potential But With Caveats KalVista: Next Stage Of Growth For EKTERLY Lies With Pediatric Label Expansion KalVista Pharmaceuticals Q4 2025 Earnings Preview Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag Seeking Alpha’s Quant Rating on KalVista Pharmaceuticals
Chewy press release ( CHWY ): Q4 Non-GAAP EPS of $0.27 misses by $0.01 . Revenue of $3.26B (+0.5% Y/Y) in-line. Adjusted EBITDA of $162.3 million, an increase of $37.8 million year over year. Adjusted EBITDA margin of 5.0 percent expanded 120 basis points year over year. More on Chewy Chewy: A Defensive Staple For An Uncertain Economy Chewy, Inc. (CHWY) Presents at Morgan Stanley Technology, Media...
Chewy press release ( CHWY ): Q4 Non-GAAP EPS of $0.27 misses by $0.01 . Revenue of $3.26B (+0.5% Y/Y) in-line. Adjusted EBITDA of $162.3 million, an increase of $37.8 million year over year. Adjusted EBITDA margin of 5.0 percent expanded 120 basis points year over year. More on Chewy Chewy: A Defensive Staple For An Uncertain Economy Chewy, Inc. (CHWY) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Chewy: Improving Fundamentals, But Not A Buy Quite Yet Chewy Q4 2026 Earnings Preview Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
Winnebago press release ( WGO ): Q2 Non-GAAP EPS of $0.27 beats by $0.03 . Revenue of $657.4M (+6.0% Y/Y) beats by $30.24M . Gross profit of $85.6 million, representing 13.0% gross margin, compared to $83.1 million in the second quarter of Fiscal 2025 Net income of $4.8 million, or $0.17 per diluted share; adjusted earnings per diluted share of $0.27 compared to adjusted earnings per diluted share...
Winnebago press release ( WGO ): Q2 Non-GAAP EPS of $0.27 beats by $0.03 . Revenue of $657.4M (+6.0% Y/Y) beats by $30.24M . Gross profit of $85.6 million, representing 13.0% gross margin, compared to $83.1 million in the second quarter of Fiscal 2025 Net income of $4.8 million, or $0.17 per diluted share; adjusted earnings per diluted share of $0.27 compared to adjusted earnings per diluted share of $0.19 in the second quarter of Fiscal 2025 Adjusted EBITDA of $24.4 million, up 7.0% year-over-year 2026 outlook: Consolidated net revenues in the range of $2.8 billion to $3.0 billion (vs. consensus of $2.92B) Reported earnings per diluted share in the range of $1.50 to $2.20 compared to the Company's prior expectations for reported earnings per diluted share in the range of $1.40 to $2.10; and Adjusted earnings per diluted share guidance to a range of $2.10 to $2.80. (vs. consensus of 2.46) More on Winnebago Winnebago Industries, Inc. (WGO) Presents at 47th Annual Raymond James Institutional Investor Conference - Slideshow Winnebago: Issues Remain, But An Upgrade From Sell To Hold Seems Justified Winnebago: Still Winning With Robust Fundamentals In The Current Market Dynamics Winnebago Q2 2026 Earnings Preview Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
MBA Mortgage Applications Composite Index: -10.5% to 310.7, compared to -10.9% to 347.1 in the prior week. Purchase Index: -5.4% to 163.6, vs. +0.9% to 172.9 a week ago. Refinance Index: -14.6% to 1,145.0, vs. -18.5% to 1,341.0 prior. 30-year fixed-rate mortgages came in at 6.43%, compared to 6.30% last week. “The threat of higher for longer oil prices continued to keep Treasury yields elevated, a...
MBA Mortgage Applications Composite Index: -10.5% to 310.7, compared to -10.9% to 347.1 in the prior week. Purchase Index: -5.4% to 163.6, vs. +0.9% to 172.9 a week ago. Refinance Index: -14.6% to 1,145.0, vs. -18.5% to 1,341.0 prior. 30-year fixed-rate mortgages came in at 6.43%, compared to 6.30% last week. “The threat of higher for longer oil prices continued to keep Treasury yields elevated, and mortgage rates finished last week higher. The 30-year fixed rate rose to 6.43 percent, more than 30 basis points higher than at the end of February and at its highest level since October 2025,” said Joel Kan, MBA’s vice president and deputy chief economist. “Higher mortgage rates, coupled with affordability constraints and economic uncertainty, pushed some potential homebuyers to the sidelines,” Kan added. More on mortgages Gold Loses Its Luster As Stagflation Risk Jumps On Iran War War And Bonds Calming Inflationary Fears Is Job Number One A move above 4.5% on the US10Y would be a ‘tipping point’ for stocks – Schroders US2Y surges toward 4% as weak auction signals cracks in demand
Investing.com -- Shares of Arm Holdings have jumped 13% premarket on Wednesday after upbeat assessments from analysts, who said the company’s first internally built processor marks a major expansion of its business model and long-term earnings power.
Investing.com -- Shares of Arm Holdings have jumped 13% premarket on Wednesday after upbeat assessments from analysts, who said the company’s first internally built processor marks a major expansion of its business model and long-term earnings power.
Hong Kong’s universities have recorded their sharpest declines in three years in global subject rankings, with more than half of the 266 offerings – including data science and AI – slipping down their respective tables, according to a UK-based education analyst. Despite the overall drop, dentistry at the University of Hong Kong (HKU) remained second in the world – the city’s highest-ranked subject...
Hong Kong’s universities have recorded their sharpest declines in three years in global subject rankings, with more than half of the 266 offerings – including data science and AI – slipping down their respective tables, according to a UK-based education analyst. Despite the overall drop, dentistry at the University of Hong Kong (HKU) remained second in the world – the city’s highest-ranked subject – while performing arts at the Hong Kong Academy for Performing Arts (HKAPA) regained its 10th...